When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. A diabetes drug may help prevent dementia, new research shows

   www.aol.com/diabetes-drug-may-help-prevent...

   When the scientists looked at dementia subtypes, they found that SGLT-2 inhibitors were linked to 52% lower risk of vascular dementia, and 39% lower risk of Alzheimer’s disease.

3. Why do some researchers believe metformin may hold the key to ...

   www.aol.com/lifestyle/why-researchers-believe...

   For premium support please call: 800-290-4726 more ways to reach us

4. Dementia risk may be lowered by one important medical device

   www.aol.com/dementia-risk-may-lowered-one...

   A 2017 study published in JAMA Neurology, which followed more than 15,000 adults over time, found that diabetes is also an independent risk factor for dementia, along with smoking and high blood ...

5. Metformin - Wikipedia

   en.wikipedia.org/wiki/Metformin

   A 2017 review found that people with diabetes who were taking metformin had lower all-cause mortality. [231] They also had reduced cancer and cardiovascular disease compared with those on other therapies. [231] In people without diabetes, metformin does not appear to reduce the risk of cancer and cardiovascular disease. [237]

6. Type 3 diabetes - Wikipedia

   en.wikipedia.org/wiki/Type_3_diabetes

   Type 3 diabetes is a proposed pathological linkage between Alzheimer's disease and certain features of type 1 and type 2 diabetes. [1] Specifically, the term refers to a set of common biochemical and metabolic features seen in the brain in Alzheimer's disease, and in other tissues in diabetes; [1] [2] it may thus be considered a "brain-specific type of diabetes."

7. Alpha-glucosidase inhibitor - Wikipedia

   en.wikipedia.org/wiki/Alpha-glucosidase_inhibitor

   It was found that Acarbose appeared to reduce incidence of diabetes mellitus type 2 when compared to placebo, however there was no conclusive evidence that acarbose compare to diet and exercise, metformin, placebo, no intervention improved all-cause mortality, reducer or increased risk of cardiovascular mortality, serious or non-serious adverse ...